Listed

Sono Tek Corp: Form 10-Q for the period ended Nov 30, 2024

Filed with the SEC on Jan 13, 2025 and accepted by EDGAR at Jan 13, 2025, 13:43 ET.

Share

Management's discussion and analysis

As filed, 35,347 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

FORWARD-LOOKING STATEMENTS

We discuss expectations regarding our future performance, such as our business outlook, in our annual and quarterly reports, news releases, and other written and oral statements. These “forward-looking statements” are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; inflationary and supply chain pressures; the recovery of the Electronics/Microelectronics and Medical markets; rebound of sales to the industrial market in the fourth quarter of fiscal year 2025; continued depletion of excess inventory created by our OEM Partners; continued positive impact of recent distributor changes on the Printed Circuit Board revenues; maintenance of increased order backlog; the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the medical and alternative energy markets; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems which are sold at higher average selling prices; and realization of quarterly and annual revenues within the forecasted range of sales guidance.

We undertake no obligation to update any forward-looking statement.

Overview

Founded in 1975, Sono-Tek Corporation is a global leader in designing and manufacturing ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems are used to apply thin films onto parts used in diverse industries, including microelectronics, alternative energy, medical devices, advanced industrial manufacturing, and research and development sectors worldwide. Sono-Tek’s move into the clean energy sector is showing transformative results in next-gen solar cells, fuel cells, green hydrogen generation, and carbon capture applications as we shape a sustainable future.

Our product line is rapidly evolving, transitioning from R&D to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Over the last decade, we have shifted our business from primarily selling ultrasonic nozzles and components to providing complete machine solutions and higher-value subsystems to original equipment manufacturers (OEMs). This strategy has resulted in significant growth of our average unit selling price, with our larger machines often selling for over $300,000 and system prices sometimes reaching over $1,000,000. Consequently, we have broadened our addressable market and believe we can grow sales on a larger scale. We expect that we will experience wide variations in both order flow and shipments from quarter to quarter.

Our comprehensive suite of thin film coating solutions and application consulting services, provided by our expert applications engineers to guide our customers in developing the complete coating process, ensures unparalleled results for our clients and helps some of the world’s most promising companies achieve technological breakthroughs and bring them to market. In anticipation of customer demands, our significant focus on R&D efforts allows us to keep pace with industry trends while continuously innovating. The company strategically delivers its products through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives located in North America, Latin America, Europe, and Asia, ensuring efficient market reach across diverse sectors around the globe. Approximately 39% of our sales were generated outside the United States and Canada in the first nine months of fiscal year 2025.

We continue to expand our sales capabilities by increasing the size of our direct sales force and adding new distributors and sales representatives. In addition, we have established testing labs at our distribution partner sites in China, Taiwan, Germany, Turkey, Korea, and Japan, while also expanding our first testing lab co-located with our manufacturing facilities in New York. These labs provide significant value for demonstrating the capabilities of our equipment to prospective customers and enable us to develop custom solutions to meet their needs.

Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to develop thin-film coating technologies that enable better outcomes for our customers’ products and processes.

Third Quarter Fiscal 2025 Highlights (compared with the third quarter of fiscal 2024 unless otherwise noted) We refer to the three-month periods ended November 30, 2024 and 2023 as the third quarter of fiscal 2025 and fiscal 2024, respectively.

  • Net sales decreased by 9% or $499,000 to $5,191,000 when compared to last year’s record quarterly results of $5,690,000 and up sequentially from $5,162,000 in the second quarter of fiscal 2025. The decrease in sales in the current period is due to lower sales in the Industrial and Medical markets and reduced revenue from the US and EMEA regions when compared to the prior year period.
  • Sales to the Alternative/Clean Energy market grew 42% to $3,000,000 and included a $1,120,000 production line system for Electrolyzer Coating. The increase was offset by decreases in all other markets.
  • Asia Pacific (APAC) sales increased by 64%, influenced by strong sales to South Korea, which included three separate systems with a combined value of $248,000 and a $300,000 system shipped to India for the clean energy sector.
  • Gross Profit decreased 20% or $583,000 to $2,343,000. The gross profit percentage decreased by 600 basis points to 45% compared to an all-time high of 51% in the third quarter of fiscal 2024. The decrease in gross profit is primarily due to product mix, an increased percentage of international sales that carry distributor discounted pricing and the reclass of specific labor expenses from the engineering department to cost of goods sold.
  • Operating Income decreased 73% or $523,000, to $198,000 and income before taxes decreased $576,000, from $890,000 to $314,000 primarily due to the current periods decrease in gross profit.
  • Operating expenses decreased 3% or $60,000 to $2,146,000, primarily driven by a 19% decrease in Research & Development expenditures.
  • Combined equipment and service-related backlog on November 30, 2024 remained strong at $10,564,000, which is a slight decrease of $107,000 when compared to the combined backlog of $10,671,000 at November 30, 2023.

Nine Month Fiscal 2025 Highlights (compared with the first nine months of fiscal 2024 unless otherwise noted) We refer to the nine-month periods ended November 30, 2024 and 2023 as the first nine-months of fiscal 2025 and fiscal 2024, respectively.

  • Net Sales for the first nine months of fiscal 2025 increased by 3% or $451,000 to $15,383,000, driven by increased sales of multi-axis sales coating systems and integrated coating systems, primarily to the clean energy market.
  • Sales to the Alternative Energy market increased by 63%, or $3,000,000 to $7,700,000 compared with $4,735,000 in the prior year period. The increase in revenue is due to several high volume, high ASP “Average Selling Price” systems being delivered for advanced solar and electrolysis related applications.
  • Gross Profit decreased 3% or $190,000 to $7,314,000. The Gross profit percentage decreased by 200 basis points to 48% compared with 50% in the prior year period. The decrease in gross profit is due to product mix and the reallocation and recharacterization of specific labor expenses from the engineering department to cost of goods sold.
  • Operating Income decreased 40%, or $473,000 to $722,000 and income before taxes decreased $486,000 or 30% to $1,120,000 due to the decrease in gross profit combined with an increase in operating expenses.
  • Geographically, revenue increased in the US/Canada, Asia and EMEA by 5%, 11% and 9%, respectively.
  • As of November 30, 2024, the Company had no outstanding debt and had cash, cash equivalents and marketable securities totaling $12,681,000.

12

RESULTS OF OPERATIONS

Sales:

Product Sales

Three Months Ended November 30, 2024 2023 Change $% Nine Months Ended November 30, 2024 2023 Change $%
Fluxing Systems $71,000 $62,000 9,000 15% $324,000 $503,000 (179,000) (36%)
Integrated Coating Systems 81,000 1,418,000 (1,337,000) (94%) 2,850,000 2,579,000 271,000 11%
Multi-Axis Coating Systems 3,563,000 2,962,000 601,000 20% 8,158,000 7,648,000 510,000 7%
OEM Systems 259,000 268,000 (9,000) (3%) 796,000 1,078,000 (282,000) (26%)
Other 1,217,000 980,000 237,000 24% 3,255,000 3,124,000 131,000 4%
TOTAL $5,191,000 $5,690,000 (499,000) (9%) $15,383,000 $14,932,000 451,000 3%

Total sales for the first nine months of fiscal year 2025 grew by 3%, and total sales for the third quarter of fiscal 2025 decreased by 9%. The increase in revenue for the first nine months of fiscal 2025 is the result of an 11% increase in Integrated Coating Systems revenue and a 7% increase in Multi Axis Coating Systems revenue. For the third quarter of fiscal 2025, sales of our Integrated Coating Systems decreased by 94%, but this decrease was partially offset by a 20% increase in Multi Axis Coating Systems revenue.

OEM Systems revenue for the third quarter and first nine months of fiscal year 2025 decreased by 3% and 26%, respectively. The decrease is primarily due to OEM partners previously building up excess inventory to combat supply chain concerns. There are indications that this excess inventory created by OEM Partners has been cleared during the third quarter of fiscal 2025.

Fluxing Systems revenue for the third quarter of fiscal 2025 increased 15% and decreased 36% for the first nine months of fiscal 2025. The first nine-month dip was influenced by softening activity from the Printed Circuit Board Sector, however due to significant positive momentum resulting from recent distributor changes, we anticipate that this revenue stream will have continued growth for the remainder of the fiscal year.

The Other revenue category increased by 24% in the third quarter of fiscal 2025 and 4% for the first nine months of fiscal 2025. This category comprises spare parts sales and service-related activities, with the latter experiencing particularly strong performance in the third quarter of fiscal 2025, highlighting service-related revenue as an important contributor to growth.

Market Sales

Three Months Ended November 30, 2024 2023 Change $% Nine Months Ended November 30, 2024 2023 Change $%
Electronics/Microelectronics $1,016,000 $1,374,000 (358,000) (26%) $4,060,000 $3,724,000 336,000 9%
Medical 897,000 1,340,000 (443,000) (33%) 2,156,000 3,452,000 (1,296,000) (38%)
Alternative Energy 2,959,000 2,083,000 876,000 42% 7,740,000 4,735,000 3,005,000 63%
Emerging R&D and Other 17,000 152,000 (135,000) (89%) 57,000 315,000 (258,000) (82%)
Industrial 302,000 741,000 (439,000) (59%) 1,370,000 2,706,000 (1,336,000) (49%)
TOTAL $5,191,000 $5,690,000 (499,000) (9%) $15,383,000 $14,932,000 451,000 3%

Sales to the Alternative/Clean Energy market recorded growth of 42% in the third quarter of fiscal 2025, and 63% for the first nine months of fiscal 2025, which were positively impacted by a growing number of our customers transitioning from our R&D systems to production scale systems that carry much higher average selling prices.

Electronics market revenue increased for the first nine months of fiscal 2025, influenced by the introduction of newly developed products in the semiconductor market.

Medical sales revenue decreased in the third quarter of fiscal 2025 and the first nine months of fiscal 2025 due to decreased medical sales in China, resulting from a weak Chinese economy, increased competition in mainland China, and a strong push for China based companies to buy “Made in China” products. Sales to China have declined to a level where they no longer represent a significant portion of our overall revenue. As such, any further decreases in sales to this region are not expected to have a material impact on our financial performance.

Industrial sales declined by 59% and 49%, respectively, for the third quarter of fiscal 2025 and the first nine months of fiscal 2025. The reduction in industrial sales was strongly impacted by approximately $930,000 of sales to the float glass industry in the first nine months of fiscal 2024 that did not repeat in fiscal 2025. The businesses of our primary American based customers in this market have contracted due to China-based competition entering the market with inexpensive glass.

Geographic Sales

Three Months Ended November 30, 2024 2023 Change $% Nine Months Ended November 30, 2024 2023 Change $%
U.S. & Canada $2,823,000 $3,421,000 (598,000) (17%) $9,409,000 $8,988,000 421,000 5%
Asia Pacific (APAC) 1,114,000 681,000 433,000 64% 1,994,000 1,790,000 204,000 11%
Europe, Middle East, Asia (EMEA) 957,000 1,476,000 (519,000) (35%) 3,338,000 3,057,000 281,000 9%
Latin America 297,000 112,000 185,000 165% 642,000 1,097,000 (455,000) (41%)
TOTAL $5,191,000 $5,690,000 (499,000) (9%) $15,383,000 $14,932,000 451,000 3%

In the first nine months of fiscal 2025, approximately 39% of sales originated outside of the United States and Canada compared with 40% in the first nine months of fiscal 2024.

In the third quarter of fiscal 2025, approximately 46% of sales originated outside of the United States and Canada compared with 40% in the third quarter of fiscal 2024.

We continue to record strong sales from the U.S. and Canada compared to past years, with the first nine-month revenue up 5% or $421,000. U.S. government initiatives such as the CHIPS ACT and the Inflation Reduction Act have influenced these strong sales, as well as the continuing trend of onshoring for high technology products

Asia sales increased 64% and 11% respectively, for the third quarter of fiscal 2025 and first nine months of fiscal 2025. While China sales continue to decline, growth for the first nine months of fiscal 2025 continues from South Korea, India, Taiwan and Japan.

Latin America sales in the third quarter of fiscal 2025 increased by $185,000, or 165% primarily due to an orthopedic medical device coating system that shipped for $133,000. Sales for the first nine months of fiscal 2025 decreased by $455,000, or 41% due to a $465,000 float glass line that was shipped in fiscal 2024 that did not repeat in fiscal 2025.

Gross Profit:

Three Months Ended November 30, 2024 2023 Change $% Nine Months Ended November 30, 2024 2023 Change $%
Net Sales $5,191,000 $5,690,000 (499,000) (9%) $15,383,000 $14,932,000 451,000 3%
Cost of Goods Sold 2,848,000 2,764,000 (84,000) (3%) 8,069,000 7,428,000 (641,000) (9%)
Gross Profit $2,343,000 $2,926,000 (583,000) (20%) $7,314,000 $7,504,000 (190,000) (3%)
Gross Profit % 45% 51% 48% 50%

For the third quarter of fiscal 2025, gross profit decreased $583,000, or 20%, compared with the third quarter of fiscal 2024. For the third quarter of fiscal 2025, the gross profit margin was 45% compared with 51% for the prior year period. The decrease in the gross profit margin was influenced by product mix, increased International Sales that most commonly have distributor discounts, and the reallocation and recharacterization of specific labor expenses from the engineering department to cost of goods sold that started in the fourth quarter of fiscal year 2024 as an outcome of the completion of several successful R&D endeavors.

Gross profit decreased $190,000, or 3%, to $7,314,000 for the first nine months of fiscal 2025 compared with $7,504,000 in the first nine months of fiscal 2024. The gross profit margin was 48% compared with 50% for the prior year period. The decrease in the gross profit margin was influenced by product mix and the reallocation and recharacterization of specific labor expenses from the engineering department to cost of goods sold that started in the fourth quarter of fiscal year 2024 as an outcome of completion of several successful R&D endeavors.

Operating Expenses:

Three Months Ended November 30, 2024 2023 Change $% Nine Months Ended November 30, 2024 2023 Change $%
Research and product development $628,000 $776,000 (148,000) (19%) $2,055,000 $2,222,000 (167,000) (8%)
Marketing and selling 929,000 955,000 (26,000) (3%) 2,815,000 2,700,000 115,000 4%
General and administrative 589,000 474,000 115,000 24% 1,722,000 1,387,000 335,000 24%
Total Operating Expenses $2,146,000 $2,205,000 $(59,000) (3%) $6,592,000 $6,309,000 $283,000 4%

Research and Product Development:

Research and product development costs decreased in the third quarter and the first nine months of fiscal 2025 due to a decrease in salary associated with the departure of a senior engineer, a decrease in research and development materials and the reallocation and recharacterization of specific labor expenses from the engineering department to cost of goods sold that started in the fourth quarter of fiscal year 2024. The reallocation of the labor expenses is an outcome of the completion of several successful R&D endeavors.

Marketing and Selling:

Marketing and selling expenses decreased slightly in the third quarter of fiscal 2025 due to a decrease in salary expense which was partially offset by an increase in commissions.

Marketing and selling expenses increased in the first nine months of fiscal 2025 due to increased commissions and increased travel and trade show expenses. In the third quarter of fiscal 2025, we expended approximately $222,000 for commissions as compared with $178,000 for the prior year period, an increase of $44,000. In the first nine months of fiscal 2025, we expended approximately $628,000 for commissions as compared with $464,000 for the prior year period, an increase of $164,000. The increase in commission expense is primarily the result of an increase in sales being generated by our external distributors, which are commissioned at a higher rate than our in-house sales team.

The decrease in salary expense is due to the reallocation of our Chief Executive Officer, Steve Harshbarger’s salary to the General and Administrative category as described more fully below under the heading “General and Administrative”.

General and Administrative:

General and administrative expenses increased in both the third quarter and first nine months of fiscal 2025 due to increased salaries, legal and audit fees, corporate expenses and stock based compensation. These increases were partially offset by the reversal of the sales tax accrual described more fully below.

The increase in stock based compensation expense in the third quarter of fiscal 2025 is due to option awards that were issued in the second quarter of fiscal 2025. Option awards are expensed over three years based on vesting.

Effective January 1, 2024, Steve Harshbarger became our Chief Executive Officer, having previously served as President prior to such date. On becoming Chief Executive Officer, we reclassified the expenses related to Mr. Harshbarger's compensation in connection with this positional change. Prior to January 1, 2024, we classified Mr. Harshbarger’s salary under sales expenses because of Mr. Harshbarger’s instrumental role in that area. For the first nine months of fiscal year 2025, the total reallocated amount of Mr. Harshbarger’s salary was approximately $194,000.

In the fourth quarter of fiscal 2024, we were notified by the State of California that we were required to collect sales tax on our shipments to customers in California. For taxable sales, we collected approximately $86,000 of delinquent sales tax from our customers in the first nine months of fiscal 2025. As of February 29, 2024, on the basis of a preliminary analysis of our sales to our California customers since April 1, 2019, we recorded an accrual in the amount of $138,000 for the estimated sales tax, penalties and interest that we may have been required to remit to the State of California.

In the second quarter of fiscal 2025, we filed all necessary sales tax returns with the State of California. Our net expense for sales tax and interest amounted to $72,000. In the second quarter of fiscal 2025, we reversed the remaining accrual of $66,000. This reversal is recorded in general and administrative expenses.

Operating Income:

In the third quarter of fiscal 2025, operating income decreased $523,000, or 73%, to $198,000 compared with $721,000 for the third quarter of fiscal 2024. Operating margin for the third quarter of fiscal 2025 was 4% compared with 13% in the prior year period. The current period’s decrease in operating income is a result of a decrease in revenue and gross profit partially offset by a decrease in operating expenses.

In the first nine months of fiscal 2025, operating income decreased $473,000, or 40%, to $722,000 compared with $1,195,000 for the first nine months of fiscal 2024. Operating margin for the first nine months of fiscal 2025 was 5% compared with 8% in the prior year period. In the first nine months of fiscal 2025, the decrease in operating income is a result of a decrease in gross profit combined with an increase in operating expenses.

Interest, Dividend Income and Unrealized Gain/(Loss):

Interest and dividend income decreased by $18,000 to $132,000 in the third quarter of fiscal 2025 as compared with $150,000 for the third quarter of fiscal 2024, reflecting a minor reduction in interest rates earned on our cash balances in the third quarter of fiscal 2025. In the first nine months of fiscal 2025, interest and dividend income decreased by $21,000 to $359,000 as compared with $380,000 for the first nine months of fiscal 2024. Our present investment policy is to invest excess cash in highly liquid, low risk US Treasury securities. At November 30, 2024, the majority of our holdings are rated at or above investment grade.

Net unrealized gain decreased to a $15,000 net unrealized loss in the third quarter of fiscal 2025 compared to a gain of $20,000 in the prior year period. In the first nine months of fiscal 2025, net unrealized gain increased $8,000 to $39,000 compared with $31,000 in the prior year period.

Income Tax Expense:

We recorded income tax expense of $40,000 for the third quarter of fiscal 2025 compared with $200,000 for the third quarter of fiscal 2024. For the first nine months of fiscal 2025 we recorded income tax expense of $174,000 compared with $321,000 for the first nine months of fiscal 2024.

The decrease in income tax expense in the third quarter fiscal 2025 is due to the decrease in income before income taxes partially offset by an increase in permanent timing differences and then the further reduction of taxes due to the application of available research and development tax credits from the current quarter’s increase in research and development expenditures. The deferred tax asset increased approximately $255,000, to $1,511,000 at November 30, 2024 from $1,256,000 at February 29, 2024. Additionally, the deferred tax liability increased approximately $87,000, to $317,000 at November 30, 2024 from $230,000 at February 29, 2024. The net increase in the deferred tax asset and liability was approximately $168,000 for the first nine months of fiscal 2025. This increase is primarily due to an increase in capitalized research and development expenses for tax purposes, partially offset by a decrease in other deferred tax assets and an increase in deferred tax liabilities related to timing differences for depreciation.

Net Income:

Net income decreased by $416,000 or 60% to $274,000 for the third quarter of fiscal 2025 compared with $690,000 for the third quarter of fiscal 2024. The decrease in net income during the third quarter is primarily the result of a decrease in revenue and gross profit combined with decreases in operating expenses and income tax expense.

Net income decreased by $339,000 or 26% to $946,000 for the first nine months of fiscal 2025 compared with $1,285,000 for the first nine months of fiscal 2024. The decrease in net income in the first nine months of fiscal 2025 is primarily the result of a decrease in gross profit combined with decreases in operating expenses and income tax expense.

Liquidity and Capital Resources

Working Capital – Our working capital increased $1,079,000 to $13,202,000 at November 30, 2024 from $12,123,000 at February 29, 2024. The increase in working capital was mostly the result of the current period’s net income and noncash charges partially offset by purchases of equipment.

We aggregate cash and cash equivalents and marketable securities in managing our balance sheet and liquidity. For purposes of the following analysis, the total is referred to as “Cash.” At November 30, 2024 and February 29, 2024, our working capital included:

November 30, 2024 February 29, 2024 Cash Increase (Decrease)
Cash and cash equivalents $8,099,000 $2,135,000 $5,964,000
Marketable securities 4,582,000 9,712,000 (5,130,000)
Total $12,681,000 $11,847,000 $834,000

The following table summarizes the accounts and the major reasons for the $834,000 increase in “Cash”:

Impact on Cash Reason
Net income, adjusted for non-cash items $1,515,000 To reconcile increase in cash.
Accounts receivable increase (809,000) Timing of cash receipts.
Inventories decrease 452,000 Decrease in work in progress and finished goods for customer orders.
Customer deposits decrease (56,000) Completion of customer orders.
Accounts payable increase 67,000 Timing of disbursements.
Accrued expenses increase 186,000 Timing of disbursements.
Prepaid and Other Assets decrease 84,000 Decreased prepaid expenses.
Income taxes payable decrease (202,000) Timing of disbursements.
Equipment purchases (403,000) Equipment and facilities upgrade.
Net increase in cash $834,000

Stockholders’ Equity – Stockholders’ Equity increased $1,122,000 from $16,279,000 at February 29, 2024 to $17,401,000 at November 30, 2024. The increase is a result of the current period’s net income of $946,000 and $176,000 in additional equity related to stock-based compensation awards.

Operating Activities – We generated $1,199,000 of cash in our operating activities in the first nine months of fiscal 2025 compared with $1,442,000 of cash in the first nine months of fiscal 2024, a decrease of $243,000. The decrease was mostly the result of increases in accounts receivable, a decrease in income taxes payable offset by decreases in inventories and customer deposits. The increase in accounts receivable is due to a number of large sales occurring in the last month of the quarter.

Investing Activities– Our investing activities provided $4,765,000 of cash in the first nine months of fiscal 2025 compared with using $1,815,000 in the first nine months of 2024. For the first nine months of fiscal years 2025 and 2024, we used $403,000 and $327,000, respectively, for the purchase or manufacture of equipment, furnishings and leasehold improvements.

In the first nine months of fiscal 2025, we liquidated approximately $5,318,000 of our treasury bill investments. At November 30, 2024, approximately $3,583,000 of the liquidated balance is recorded as cash on our balance sheet and is invested in cash equivalents.

Net Changes in Cash and Cash Equivalents – In the first nine months of fiscal 2025, our cash balance increased by $5,964,000 as compared to a decrease of $373,000 in the first nine months of 2024. In the first nine months of fiscal 2025, our operating activities generated $1,199,000 of cash, our marketable securities provided $5,168,000 of cash and we used $403,000 for the purchase or manufacture of equipment, furnishings and leasehold improvements.

Critical Accounting Estimates

The discussion and analysis of the Company’s financial condition and results of operations are based upon the consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure on contingent assets and liabilities at the date of the financial statements. Actual results may differ from these estimates under different assumptions and conditions.

Management’s estimates and judgements are continually evaluated and are based on historical experience and expectations regarding future events that are believed to be reasonable under the specific circumstances.

Critical accounting estimates are defined as those that are reflective of significant judgments and uncertainties and may potentially result in materially different results under different assumptions and conditions. The Company believes that critical accounting policies are limited to those described below. For a detailed discussion on the application of these and other accounting policies see Note 2 to the Company’s consolidated financial statements included in Form 10-K for the year ended February 29, 2024.

Accounting for Income Taxes

The Company accounts for income taxes under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. We use a recognition threshold and a measurement attribute for financial statement recognition and measurement tax positions taken or expected to be taken in a return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. As of November 30, 2024 and November 30, 2023, there were no uncertain tax provisions.

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.

Judgement is required when determining at what point in time control of the Company’s manufactured equipment is transferred to its customers. Management’s judgement is based on each customer contract and the transfer of control of the equipment to the customer. The sales revenue to be recorded is based on each contract.

Impact of New Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures, and does not expect the standard will have a material impact on the Company’s consolidated financial statements and related disclosures.

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. This ASU requires greater disaggregation of information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. This ASU applies to all entities subject to income taxes and is intended to help investors better understand an entity’s exposure to potential changes in jurisdictional tax legislation and assess income tax information that affects cash flow forecasts and capital allocation decisions. This ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact the adoption of this ASU will have on its consolidated financial statements and related disclosures.

Other than ASU 2023-07 and ASU 2023-09 discussed above, accounting pronouncements issued but not yet effective have been deemed to be not applicable or the adoption of such accounting pronouncements is not expected to have a material impact on the financial statements of the Company.

Market risk

As filed, 537 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company does not issue or invest in financial instruments or derivatives for trading or speculative purposes. Substantially all of the operations of the Company are conducted in the United States, and, as such, are not subject to material foreign currency exchange rate risk. All of our sales transactions are completed in US dollars.

Although the Company's assets included $8,099,000 in cash and $4,582,000 in marketable securities, the market rate risk associated with changing interest rates in the United States is not material.

Controls and procedures

As filed, 1,287 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company has established and maintains “disclosure controls and procedures” (as those terms are defined in Rules 13a –15(e) and 15d-15(e) under the Securities and Exchange Act of 1934 (the “Exchange Act”). R. Stephen Harshbarger, Chief Executive Officer (principal executive) and Stephen J. Bagley, Chief Financial Officer (principal accounting officer) of the Company, have evaluated the Company’s disclosure controls and procedures as of November 30, 2024. Based on this evaluation, they have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding timely disclosure.

In addition, there were no changes in the Company’s internal controls over financial reporting during the third fiscal quarter of fiscal year 2025 that have materially affected, or are reasonably likely to materially affect, internal controls over financial reporting.

Risk factors

As filed, 150 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There are no material changes from risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the year ended February 29, 2024.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-11-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-09-01 to 2024-11-30$5.2mus-gaap:Revenues
Revenue9 months2024-03-01 to 2024-11-30$15.4mus-gaap:Revenues
Cost of revenue3 months2024-09-01 to 2024-11-30$2.8mus-gaap:CostOfRevenue
Cost of revenue9 months2024-03-01 to 2024-11-30$8.1mus-gaap:CostOfRevenue
Gross profit3 months2024-09-01 to 2024-11-30$2.3mus-gaap:GrossProfit
Gross profit9 months2024-03-01 to 2024-11-30$7.3mus-gaap:GrossProfit
Research and development3 months2024-09-01 to 2024-11-30$627.5kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2024-03-01 to 2024-11-30$2.1mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2024-09-01 to 2024-11-30$197.6kus-gaap:OperatingIncomeLoss
Operating income9 months2024-03-01 to 2024-11-30$721.9kus-gaap:OperatingIncomeLoss
Income tax3 months2024-09-01 to 2024-11-30$39.8kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-03-01 to 2024-11-30$174.2kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-09-01 to 2024-11-30$274.2kus-gaap:NetIncomeLoss
Diluted EPS3 months2024-09-01 to 2024-11-30$0.02us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-03-01 to 2024-11-30$0.06us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-09-01 to 2024-11-30$0.02us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-03-01 to 2024-11-30$0.06us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-09-01 to 2024-11-3015,771,511 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-03-01 to 2024-11-3015,771,039 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-03-01 to 2024-11-30$1.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2024-03-01 to 2024-11-30$403.1kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2024-11-30$8.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-11-30$19.8mus-gaap:AssetsCurrent
Total assetsAt period end2024-11-30$24.3mus-gaap:Assets
Current liabilitiesAt period end2024-11-30$6.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-11-30$6.9mus-gaap:Liabilities
Shareholders' equityAt period end2024-11-30$17.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001171520-25-000009. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.